201 related articles for article (PubMed ID: 22302231)
1. Assessing the real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu positive breast cancer.
Hedden L; O'Reilly S; Lohrisch C; Chia S; Speers C; Kovacic L; Taylor S; Peacock S
Oncologist; 2012; 17(2):164-71. PubMed ID: 22302231
[TBL] [Abstract]
